Erythropoietin activates nitric oxide synthase in murine erythrocytes

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 2, 2009, Pages

  Mihov, Deyan ^a   Vogel, Johannes ^a   Gassmann, Max ^a   Bogdanova, Anna ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Nitric oxide production; Phosphatidylinositol 3 kinase Akt pathway; Red blood cells; Redox state

Indexed keywords

NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT ERYTHROPOIETIN; SERINE; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE; ERYTHROPOIESIS; INCUBATION TIME; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETICULOCYTE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROCYTES; ERYTHROPOIETIN; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; OXIDATION-REDUCTION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; SUPEROXIDES;

MURINAE; MUS;

EID: 68849102575     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00543.2008     Document Type: Article

References (62)

1. Abbrecht PH, Littell JK. Plasma erythropoietin in men and mice during acclimatization to different altitudes. J Appl Physiol 32: 54-58, 1972.
2. Alfrey CP, Rice L, Udden MM, Driscoll TB. Neocytolysis: physiological down-regulator of red-cell mass. Lancet 349: 1389-1390, 1997.
3. Baciu I, Ivanof L, Pavel T, Marina C, Zirbo M, Zdrenghea C. Erythropoietin binding to the red cell membranes. Physiologie 22: 227-231, 1985.
4. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104: 2073-2080, 2004.
5. Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M, Vogel J. Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood 110: 762-769, 2007.
6. Bogdanova AY, Ogunshola OO, Bauer C, Gassmann M. Pivotal role of reduced glutathione in oxygen-induced regulation of the Na(+)/K(+) pump in mouse erythrocyte membranes. J Memb Biol 195: 33-42, 2003.
7. Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 63: 208-216, 2004.
8. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 284: H1577-H1584, 2003.
9. Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77: 2583-2590, 1991.
10. Brunini T, Resende A, Moss M, Soares de Moura R, and Mendes Ribeiro A. L-Arginine availability as a pathological mechanism in essential hypertension, chronic renal and heart failure. Vasc Dis Prev 2: 37-51, 2005.
11. Brunini TM, Roberts NB, Yaqoob MM, Ellory JC, Mann GE, and Mendes Ribeiro AC. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients. Clin Exp Pharmacol Physiol 33: 114-118, 2006.
12. Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72: 51-59, 2006.
13. Chakraborty M, Ghosal J, Biswas T, Datta AG. Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase, and glutathione peroxidase of rat RBC. Biochem Med Metab Biol 40: 8-18, 1988.
14. Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53: 515-524, 2002.
15. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59: 419-425, 2000.
16. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD Jr, Kraus D, Ho C, Gladwin MT, and Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107: 566-574, 2006.
17. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, Canaud B. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 12: 2312-2317, 1997.
18. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49: 1142-1148, 2007.
19. Dejam A, Hunter CJ, Pelletier MM, Hsu LL, Machado RF, Shiva S, Power GG, Kelm M, Gladwin MT, Schechter AN. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 106: 734-739, 2005.
20. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107: 1892-1895, 2006.
21. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med 228: 1-14, 2003.
22. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11 Suppl 1: S37-S44, 2004.
23. Ghosal J, Chakraborty M, Biswas T, Ganguly CK, Datta AG. Effect of erythropoietin on the glucose transport of rat erythrocytes and bone marrow cells. Biochem Med Metab Biol 38: 134-141, 1987.
24. Gross AW, Lodish HF. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem 281: 2024-2032, 2006.
25. Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97: 329-339, 1983.
26. Hassan K, Roguin N, Kaganov Y, Hasan S, Kristal B. Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients. Ren Fail 27: 177-182, 2005.
27. Jacob HS, Eaton JW, Yawata Y. Shortened red blood cell survival in uremic patients: beneficial and deleterious effects of dialysis. Kidney Int 2: 139-143, 1975.
28. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol 78: 183-205, 2007.
29. Jie KE, Verhaar MC, Cramer MJM, van der Putten K, Gaillard CAJM, Doevendans PA, Koomans HA, Joles JA, Braam B. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 291: F932-F944, 2006.
30. Kakhniashvili DG, Bulla LA Jr, and Goodman SR. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 3: 501-509, 2004.
31. Kim-Shapiro DB, Schechter AN, Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26: 697-705, 2006.
32. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Gödecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35: 790-796 2003.
33. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozuyaman B, Schnurch HG, Godecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rosen P, Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 107: 2943-2951, 2006.
34. Kosaka H, Seiyama A. Increased oxygen dissociation by nitric oxide from RBC. Adv Exp Med Biol 428: 349-354, 1997.
35. Linde T, Sandhagen B, Danielson BG, Wikstrom B. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin. J Int Med 231: 601-606, 1992.
36. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. QJM 87: 679-683, 1994.
37. Lutz HU. Innate immune and non-immune mediators of erythrocyte clearance. Cel Mol Biol (Noisy-le-Grand, France) 50: 107-116, 2004.
38. Lutz HU, Fasler S, Stammler P, Bussolino F, Arese P. Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidatively-stressed and in clearance of senescent red cells. Blood Cells 14: 175-203, 1988.
39. Lutz HU, Liu SC, Palek J. Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles. J Cell Biol 73: 548-560, 1977.
40. Lutz HU, Stammler P, Fasler S, Ingold M, Fehr J. Density separation of human red blood cells on self forming Percoll gradients: correlation with cell age. Biochim Biophys Acta 1116: 1-10, 1992.
41. Maarsingh H, de Boer J, Kauffman HF, Zaagsma J, Meurs H. Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness. Br J Pharmacol 142: 1293-1299, 2004.
42. Marzo F, Lavorgna A, Coluzzi G, Santucci E, Tarantino F, Rio T, Conti E, Autore C, Agati L, Andreotti F. Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis 26: 183-187, 2008.
43. Mounta P, Kempc B, Powera D. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279, 2006.
44. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25: 1551-1557, 2005.
45. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 14: 2750-2757, 2003.
46. Nemeth I, Turi S, Haszon I, Bereczki C. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis. Pediatr Nephrol 14: 13-17, 2000.
47. Ng T, Marx G, Littlewood T, Macdougall I. Recombinant erythropoietin in clinical practice. Postgrad Med J 79: 367-376, 2003.
48. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16: 335-340, 2001.
49. Rice L, Ruiz W, Driscoll T, Whitley CE, Tapia R, Hachey DL, Gonzales GF, Alfrey CP. Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Int Med 134: 652-656, 2001.
50. Risso A, Turello M, Biffoni F, Antonutto G. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Blood Cells Mol Dis 38: 83-92, 2007.
51. Santhanam AVR, Katusic ZS. Erythropoietin and cerebral vascular protection: role of nitric oxide. Acta Pharmacol Sinica 27: 1389-1394, 2006.
52. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
53. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 67: 99-145, 2005.
54. Spivak JL, Avedissian LS, Pierce JH, Williams D, Hankins WD, Jensen RA. Isolation of the full-length murine erythropoietin receptor using a baculovirus expression system. Blood 87: 926-937, 1996.
55. Stepuro TL, Zinchuk VV. Nitric oxide effect on the hemoglobin-oxygen affinity. J Physiol Pharmacol 57: 29-38, 2006.
56. Suzuki T, Dale GL. Membrane proteins in senescent erythrocytes. Biochem J 257: 37-41, 1989.
57. Trial J, Rice L. Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface. Current Pharma Des 10: 183-190, 2004.
58. Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, Gassmann M. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102: 2278-2284, 2003.
59. Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, Mayeux P. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105: 600-608, 2005.
60. Wickrema A, Krantz S, Winkelmann J, Bondurant M. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80: 1940-1949, 1992.
61. Wu G, Flynn NE, Flynn SP, Jolly CA, Davis PK. Dietary protein or arginine deficiency impairs constitutive and inducible nitric oxide synthesis by young rats. J Nutr 129: 1347-1354, 1999.
62. Yang Z, Kaye DM. Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects. Trends Cardiovasc Med 16: 118-124, 2006.